Related Experiment Video
Updated: Jul 5, 2026
05:23
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Dyspepsia and Helicobacter pylori
Michael Selgrad1, Arne Kandulski, Peter Malfertheiner
1Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Digestive Diseases (Basel, Switzerland)
|May 9, 2008
Summary
Dyspepsia, or upper abdominal pain, is common. Treating Helicobacter pylori infection offers significant symptom relief and reduces risks of gastric diseases in many patients.
Area of Science:
- Gastroenterology
- Internal Medicine
- Public Health
Background:
- Dyspepsia is a prevalent condition causing significant healthcare burden and socioeconomic costs.
- Its etiology is complex, with Helicobacter pylori infection implicated in a subset of cases.
- H. pylori is found more frequently in dyspeptic patients than in controls.
Purpose of the Study:
- To summarize the role of Helicobacter pylori in dyspepsia.
- To outline the benefits of H. pylori eradication therapy.
- To describe current management strategies for dyspepsia.
Main Methods:
- Review of population-based studies on H. pylori prevalence in dyspepsia.
- Analysis of data on the efficacy of H. pylori eradication therapy.
- Examination of clinical guidelines for dyspepsia management.
Main Results:
- H. pylori eradication therapy provides modest but significant benefits for non-ulcer dyspepsia.
- Eradication improves long-term symptoms and reduces risks of peptic ulcer disease and gastric pathologies.
- The 'test and treat' approach is recommended for dyspepsia in patients under 45 without alarm features.
Conclusions:
- H. pylori eradication is a recommended strategy for dyspepsia associated with H. pylori-induced gastritis.
- Prompt upper endoscopy is crucial for patients with alarm features to rule out serious conditions.
- Managing dyspepsia effectively involves identifying and treating underlying causes like H. pylori infection.
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
01:30Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:25Peptic Ulcer Disease I: Introduction
Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
01:27Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...